The field of personalized medicine/targeted therapies is evolving at an unprecedented rate and has the potential to revolutionize how we approach the prevention, diagnosis and treatment of diseases. This shift represents one of the most significant in modern health care: Medicine designed for many may soon be replaced by interventions prescribed for one. The Deloitte Center for Health Solutions is investigating this evolving field and studying what is necessary to realize the full promise of targeted therapies. 

	Targeted Therapies: Portfolio of Research The science of personalized therapeutics is outpacing the economics. Explore a portfolio of related research on this topic.
	Coming Soon: The ROI of Personalized Medicine Read an abstract about an upcoming research paper that forecasts the ROI for personalized therapeutics and examines some of the pricing challenges that exist.
	Report: Targeted Therapies - Navigating the Business Challenges of Personalized Medicine This report reviews the rapidly evolving field of personalized medicine and discusses the need for collaboration among all stakeholders to overcome the challenges.